Advertisement

Topics

Silence Therapeutics takes rival Alnylam to court in patent fight

08:22 EDT 4 Jul 2017 | pharmaphorum

Silence Therapeutics has launched legal action alleging that late stage drugs from rivals Alnylam and The Medicines Company infringe its intellectual property. Silence, which specialises in developing RNA-interference based technology that "silenc...

Original Article: Silence Therapeutics takes rival Alnylam to court in patent fight

NEXT ARTICLE

More From BioPortfolio on "Silence Therapeutics takes rival Alnylam to court in patent fight"

Advertisement
Quick Search
Advertisement
Advertisement